- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/768 - Oncolytic viruses not provided for in groups
Patent holdings for IPC class A61K 35/768
Total number of patents in this class: 825
10-year publication summary
|
46
|
45
|
56
|
103
|
104
|
107
|
117
|
66
|
76
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Deutsches Krebsforschungszentrum | 419 |
33 |
| Kalivir Immunotherapeutics, Inc. | 48 |
20 |
| Memorial Sloan-Kettering Cancer Center | 1890 |
19 |
| Arizona Board of Regents on behalf of Arizona State University | 2464 |
18 |
| Ruprecht-Karls-Universität Heidelberg | 249 |
18 |
| Guangzhou Virotech Pharmaceutical Co., Ltd. | 23 |
16 |
| Transgene S.A. | 128 |
16 |
| Sillajen, Inc. | 36 |
15 |
| Mayo Foundation for Medical Education and Research | 3115 |
14 |
| Duke University | 3011 |
14 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3043 |
14 |
| Bionoxx Inc. | 21 |
14 |
| Hangzhou Converd Co., Ltd. | 34 |
13 |
| National University Corporation Tottori University | 201 |
12 |
| Ottawa Hospital Research Institute | 106 |
12 |
| Ruprecht-karls-universitaet Heidelberg | 27 |
11 |
| Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts | 327 |
10 |
| Turnstone Limited Partnership | 27 |
10 |
| Turnstone Biologics Corp. | 19 |
10 |
| Seneca Therapeutics, Inc. | 12 |
10 |
| Other owners | 526 |